WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (42)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hida, H.
Right arrow Articles by Soliven, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hida, H.
Right arrow Articles by Soliven, B.

 Previous Article  |  Next Article 

The Journal of Neuroscience, September 1, 1999, 19(17):7458-7467

Regulation of Mitogen-Activated Protein Kinases by Sphingolipid Products in Oligodendrocytes

Hideki Hida, Sukehisa Nagano, Margaret Takeda, and Betty Soliven

Department of Neurology and Committee on Neurobiology, The Brain Research Institute, University of Chicago, Chicago, Illinois 60637

Sphingolipid products such as ceramide (cer), sphingosine (sph), and sphingosine-1-phosphate (SPP) are implicated in the regulation of cell growth and apoptosis. We have recently shown that cer, sph, and SPP differentially modulate ionic events in cultured oligodendrocytes (OLGs). Cer but not sph or SPP inhibits the inward rectifier (IKir) in OLGs. To further investigate the role of sphingolipid products in OLGs, we studied the effect of cer, sph, and SPP on OLG survival and on the regulation of mitogen-activated protein kinases (MAPKs). We found that cer, sph, and SPP differentially modulate OLG survival and activation of MAPK members. Cer causes OLG apoptosis, sph causes OLG lysis, and SPP does not affect OLG survival. Cer induces a preferential activation of p38alpha , whereas sph and SPP induce a preferential activation of extracellular signal-regulated kinase 2 (ERK2) in OLGs. In addition, the effect of cer on p38alpha activity is mimicked by the inhibition of IKir with Ba2+. In contrast, exposure to cer results in increased activity of ERK2 but not of p38alpha in astrocytes. Cer-induced OLG apoptosis is attenuated by a p38 inhibitor, SB203580, and by expression of a p38alpha dominant negative mutant. We conclude that p38alpha is the mediator in cer-induced OLG apoptosis and that cer-induced IKir inhibition may contribute to the sustained activation of p38alpha in OLGs.

Key words: ceramide; glial cells; apoptosis; protein kinases; lipid mediators; signal transduction


Copyright © 1999 Society for Neuroscience  0270-6474/99/19177458-10$05.00/0


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
R. P. Coelho, S. G. Payne, R. Bittman, S. Spiegel, and C. Sato-Bigbee
The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 626 - 635.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
D. P. Stirling, K. M. Koochesfahani, J. D. Steeves, and W. Tetzlaff
Minocycline as a Neuroprotective Agent
Neuroscientist, August 1, 2005; 11(4): 308 - 322.
[Abstract] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-